Dendritic and synaptic protection: Is it enough to save the retinal ganglion cell body and axon?

Journal of Neuro-Ophthalmology

Volumn 28, Issue 2, 2008, Pages 144-154

  Morquette, Junie Barbara ^a   Di Polo, Adriana ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; BRAIN; CELL STRUCTURE; DENDRITE; DENDRITIC SPINE; GLAUCOMA; HUMAN; NERVE FIBER; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; PERIKARYON; PRIORITY JOURNAL; RETINA GANGLION CELL; REVIEW; SYNAPSE; SYNAPTIC TRANSMISSION; VISUAL IMPAIRMENT; ANIMAL; CELL COMMUNICATION; METABOLISM; NERVE DEGENERATION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPTOSOME;

ANIMALS; AXONS; CELL COMMUNICATION; DENDRITES; DENDRITIC SPINES; HUMANS; NERVE DEGENERATION; OPTIC NERVE DISEASES; PRESYNAPTIC TERMINALS; RETINAL GANGLION CELLS; SYNAPSES;

EID: 52049087651     PISSN: 10708022     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNO.0b013e318177edf0     Document Type: Review

References (130)

1. Quigley HA. Glaucoma: macrocosm to microcosm: The Frieden-wald Lecture. Invest Ophthalmol Vis Sci 2005;46:2663-70.
2. Friedman DS, Wilson MR, Liebmann JM, et al. An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol 2004;138:S19-31.
3. Friedman DS, Wolfs RC, O'Colmain BJ et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol 2004;122:532-8.
4. Harbin TS Jr, Podos SM, Kolker AE, et al. Visual field progression in open-angle glaucoma patients presenting with monocular field loss. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1976;81:253-7.
5. Georgopoulos G, Andreanos D, Liokis N, et al. Risk factors in ocular hypertension. Eur J Ophthalmol 1997;7:357-63.
6. Caprioli J. Neuroprotection of the optic nerve in glaucoma. Acta Ophthalmol Scand 1997;75:364-7.
7. Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 2003;121:48-56.
8. Chen H, Weber AJ. BDNF enhances retinal ganglion cell survival in cats with optic nerve damage. Invest Ophthalmol Vis Sci 2001;42: 966-74.
9. Di Polo A, Aigner LJ, Dunn RJ, et al. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci USA 1998;95:3978-83.
10. Ji JZ, Elyaman W, Yip HK, et al. CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. Eur J Neurosci 2004;19:265-72.
11. Jo SA, Wang E, Benowitz LI. Ciliary neurotrophic factor is and axogenesis factor for retinal ganglion cells. Neuroscience 1999;89: 579-91.
12. Klocker N, Kermer P, Weishaupt JH, et al. Brain-derived neuro-trophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphati-dyl-inositol-3'-kinase/protein kinase B signaling. J Neurosci 2000; 20:6962-7.
13. Koeberle PD, Ball AK. Neurturin enhances the survival of axotomized retinal ganglion cells in vivo: combined effects with glial cell line-derived neurotrophic factor and brain-derived neuro-trophic factor. Neuroscience 2002;110:555-67.
14. Leaver SG, Cui Q, Plant GW, et al. AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells. Gene Ther 2006;13:1328-41.
15. Mansour-Robaey S, Clarke DB, Wang YC, et al. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA 1994;91:1632-6.
16. Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res 1993;602:304-17.
17. Peinado-Ramon P, Salvador M, Villegas-Perez MP, et al. Effects of axotomy and intraocular administration of NT-4, NT-3, and brain-derived neurotrophic factor on the survival of adult rat retinal ganglion cells: a quantitative in vivo study. Invest Ophthalmol Vis Sci 1996;37:489-500.
18. Sapieha PS, Peltier M, Rendahl KG, et al. Fibroblast growth factor-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury. Mol Cell Neurosci 2003;24: 656-72.
19. van Adel BA, Arnold JM, Phipps J, et al. Ciliary neurotrophic factor protects retinal ganglion cells from axotomy-induced apo-ptosis via modulation of retinal glia in vivo. J Neurobiol 2005;63: 215-34.
20. Cheng L, Sapieha P, Kittlerova P, et al. TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci 2002;22:3977-86.
21. Park K, Luo JM, Hisheh S, et al. Cellular mechanisms associated with spontaneous and ciliary neurotrophic factor-cAMP-induced survival and axonal regeneration of adult retinal ganglion cells. J Neurosci 2004;24:10806-15.
22. Pernet V, Hauswirth WW, Di Polo A. Extracellular signal-regulated kinase 1/2 mediates survival, but not axon regeneration, of adult injured central nervous system neurons in vivo. J Neurochem 2005; 93:72-83.
23. Zhou Y, Pernet V, Hauswirth WW, et al. Activation of the extracellular signal-regulated kinase 1/2 pathway by AAV gene transfer protects retinal ganglion cells in glaucoma. Mol Ther 2005;12:402-11.
24. Chaudhary P, Ahmed F, Quebada P, et al. Caspase inhibitors block the retinal ganglion cell death following optic nerve transection. Brain Res Mol Brain Res 1999;6736-45.
25. Kermer P, Klocker N, Labes M, et al. Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J Neurosci 1998;18:4656-62.
26. Kermer P, Klocker N, Labes M, et al. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo. J Neurosci 2000;20:722-8.
27. Kugler S, Straten G, Kreppel F, et al. The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ 2000;7:815-24.
28. Malik JM, Shevtsova Z, Bähr M, et al. Long-term in vivo inhibition of CNS neurodegeneration by Bcl-XL gene transfer. Mol Ther 2005; 11:373-81.
29. McKinnon SJ, Lehman DM, Tahzib NG, et al. Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther 2002;5:780-7.
30. Straten G, Schmeer C, Kretz A, et al. Potential synergistic protection of retinal ganglion cells from axotomy-induced apoptosis by adenoviral administration of glial cell line-derived neurotrophic factor and X-chromosome-linked inhibitor of apoptosis. Neurobiol Dis 2002;11:123-3.
31. Hare W, WoldeMussie E, Lai R, et al. Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey. Surv Ophthalmol 2001;45:S284-9.
32. Hare WA, WoldeMussie E, Lai RK, et al. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures. Invest Ophthalmol Vis Sci 2004;45:2625-39.
33. Lagreze WA, Knorle R, Bach M, et al. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 1998;39:1063-6.
34. Schwartz M, Yoles E, Levin LA. 'Axogenic' and 'somagenic' neurodegenerative diseases: definitions and therapeutic implications. Mol Med Today 1999;5:470-3.
35. Cajal SR. Histology of the Nervous System of Man and Vertebrates. 1897. Swanson N, Swanson LW, trans. New York: Oxford University Press; 1995.
36. McAllister AK. Cellular and molecular mechanisms of dendrite growth. Cereb Cortex 2000;10:963-7.
37. Miller FD, Kaplan DR. Signaling mechanisms underlying dendrite formation. Curr Opin Neurobiol 2003;13:391-8.
38. Cohen-Cory S, Lom B. Neurotrophic regulation of retinal ganglion cell synaptic connectivity: from axons and dendrites to synapses. Int JDev Biol 2004;48:947-56.
39. Wong RO, Ghosh A. Activity-dependent regulation of dendritic growth and patterning. Nat Rev Neurosci. 2002;3:803-12.
40. Lom B, Cohen-Cory S. Brain-derived neurotrophic factor differentially regulates retinal ganglion cell dendritic and axonal arborization in vivo. J Neurosci 1999;19:9928-3.
41. Lom B, Cogen J, Sanchez AL, et al. Local and target-derived brain-derived neurotrophic factor exert opposing effects on the dendritic arborization of retinal ganglion cells in vivo. J Neurosci 2002;22: 7639-4.
42. Famiglietti EV Jr, Kolb H. Structural basis for ON-and OFF center responses in retinal ganglion cells. Science 1976;194:193-5.
43. Nelson R, Famiglietti EV Jr, Kolb H. Intracellular staining reveals different levels of stratification for on- and off-center ganglion cells in cat retina. J Neurophysiol 1978;41:472-83.
44. Maslim J, Stone J. Synaptogenesis in the retina of the cat. Brain Res 1986;373:35-48.
45. Bodnarenko SR, Chalupa LM. Stratification of On and Off ganglion cell dendrites depends on glutamate-mediated afferent activity in the developing retina. Nature 1993;364:144-6.
46. Tian N, Copenhagen DR. Visual stimulation is required for refinement of ON and OFF pathway in postnatal retina. Neuron 2003;39:85-96.
47. Luo L, O'Leary DD. Axon retraction and degeneration in development and disease. Annu Rev Neurosci 2005;28:127-56.
48. Grutzendler J, Helmin K, Tsai J, et al. Various dendritic abnormalities are associated with fibrillar amyloid deposits in Alzheimer's disease. Ann NY Acad Sci 2007;1097:30-9.
49. Hsieh H, Boehm J, Sato C, et al. AMPAR removal underlies A-induced synaptic depression and dendritic spine loss. Neuron 2006; 52:831-43.
50. Moolman DL, Vitolo OV, Vonsattel JP, et al. Dendrite and dendritic spine alterations in Alzheimer models. J Neurocytol 2004;33: 377-8.
51. Tsai J, Grutzendler J, Duff K, et al. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 2004;7:1181-3.
52. Day M, Wang Z, Ding J, et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006;9:251-9.
53. Deutch AY. Striatal plasticity in parkinsonism: dystrophic changes in medium spiny neurons and progression in Parkinson's disease. J Neural Transm Suppl 2006;70:67-70.
54. Solis O, Limón DI, Flores-Hernández J, et al. Alterations in dendritic morphology of the prefrontal cortical and striatum neurons in the unilateral 6-OHDA-rat model of Parkinson's disease. Synapse 2007;61:450-8.
55. Baquet ZC, Gorski JA, Jones KR. Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 2004;24:4250-8.
56. Spires TL, Grote HE, Garry S, et al. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice. Eur J Neurosci 2004;19: 2799-807.
57. Morgan JE, Datta AV, Erichsen JT, et al. Retinal ganglion cell remodelling in experimental glaucoma. Adv Exp Med Biol 2006; 572:397-402.
58. Shou T, Liu J, Wang W,. Differential dendritic shrinkage of and retinal ganglion cells in cats with chronic glaucoma. Invest Ophthalmol Vis Sci 2003;44:3005-10.
59. Weber AJ, Harman CD. Structure-function relations of parasol cells in the normal and glaucomatous primate retina. Invest Ophthalmol Vis Sci 2005;46:3197-20.
60. Weber AJ, Kaufman JP, Hubbard WC. Morphology of single ganglion cells in the glaucomatous primate retina. Invest Oph-thalmol Vis Sci 1998;39:2304-20.
61. Shou T, Liu J, Wang W. Differential dendritic shrinkage of and retinal ganglion cells in cats with chronic glaucoma. Invest Ophthalmol Vis Sci 2003;44:3005-10.
62. Morgan JE, Datta AV, Erichsen JT, et al. Retinal ganglion cell remodelling in experimental glaucoma. Adv Exp Med Biol 2006; 572:397-402.
63. Dandona L, Dandona R. What is the global burden of visual impairment? BMC Med 2006;16:4-6.
64. Foster A, Resnikoff S. The impact of Vision 2020 on global blindness. Eye 2005;19:1133-5.
65. Gabelt BT, Kaufman PL. Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res 2005;24:612-37.
66. Jackson GR, Owsley C. Visual dysfunction, neurodegenerative diseases, and aging. Neurol Clin 2003;21:709-28.
67. Balazsi AG, Rootman J, Drance SM, et al. The effect of age on the nerve fiber population of the human optic nerve. Am J Ophthalmol 1984;97:760-6.
68. Repka MX, Quigley HA. The effect of age on normal human optic nerve fiber number and diameter. Ophthalmology 1989;96:26-32.
69. Cavallotti C, Artico M, Pescosolido N, et al. Age-related changes in rat retina. Jpn J Ophthalmol 2001;45:68-75.
70. Katz ML, Robison WG Jr. Evidence of cell loss from the rat retina during senescence. Exp Eye Res 1986;42:293-304.
71. Shoji M, Okada M, Ohta A, et al. A morphological and morphometrical study of the retina in aging SAM mice. Ophthalmic Res 1998;30:172-9.
72. Weisse I. Changes in the aging rat retina. Ophthalmic Res 1995;27: 154-63.
73. Curcio CA, Millican CL, Allen KA, et al. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in the central retina. Invest Ophthalmol Vis Sci 1993;34: 3278-96.
74. Gao H, Hollyfield JG. Aging of the human retina: differential loss of neurons and retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1992;33:1-17.
75. Burke SN, Barnes CA. Neural plasticity in the ageing brain. Nat Rev Neurosci 2006;7:30-4.
76. Grill JD, Riddle DR. Age-related and laminar-specific dendritic changes in the medial frontal cortex of the rat. Brain Res 2002;937: 8-21.
77. Markham JA, Juraska JM. Aging and sex influence the anatomy of the rat anterior cingulate cortex. Neurobiol Aging 2002;23:579-88.
78. de Brabander JM, Kramers RJ, Uylings HB. Layer specific dendritic regression of pyramidal cells with ageing in the human prefrontal cortex. Eur J Neurosci 1998;10:1261-9.
79. Uylings HB, de Brabander JM. Neuronal changes in normal human aging and Alzheimer's disease. Brain Cogn 2002;49:268-76.
80. Coleman PD, Flood DG. Neuron numbers and dendritic extent in normal aging and Alzheimer's disease. Neurobiol Aging 1987;8: 521-45.
81. Barnes CA. Normal aging: regionally specific changes in hippocampal synaptic transmission. Trends Neurosci 1994;17:13-8.
82. Liets LC, Eliasieh K, van der List DA, et al. Dendrites of rod bipolar cells sprout in normal aging retina. Proc Natl Acad Sci USA 2006; 103:12156-60.
83. Eliasieh K, Liets LC, Chalupa LM. Cellular reorganization in the human retina during normal aging. Invest Ophthalmol Vis Sci 2007; 48:2824-30.
84. Yuste R, Bonhoeffer T. Genesis of dendritic spines: insights from ultrastructural and imaging studies. Nat Rev Neurosci 2004;5: 24-34.
85. Wong RO, Herrmann K, Shatz CJ. Remodeling of retinal ganglion cell dendrites in the absence of action potential activity. J Neurobiol 1991;22:685-97.
86. Wong RO, Yamawaki RM, Shatz CJ. Synaptic contacts and the transient dendritic spines of developing retinal ganglion cells. Eur J Neurosci 1992;4:1387-9.
87. Coombs J, van der List D, Wang GY, et al. Morphological properties of mouse retinal ganglion cells. Neuroscience 2006;140:123-36.
88. Dacey DM. Morphology of a small-field bistratified ganglion cell type in the macaque and human retina. Vis Neurosci 1993;10: 1081-98.
89. Wong RO. Differential growth and remodelling of ganglion cell dendrites in the postnatal rabbit retina. J Comp Neurol 1990;294: 109-32.
90. McKinney RA. Physiological roles of spine motility: development, plasticity and disorders. Biochem Soc Trans 2005;33:1299-302.
91. Sorra KE, Harris KM. Overview on the structure, composition, function, development, and plasticity of hippocampal dendritic spines. Hippocampus 2000;10:501-11.
92. Matsuzaki M, Ellis-Davies GC, Nemoto T, et al. Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons. Nat Neurosci 2001;4:1086-92.
93. Bonhoeffer T, Yuste R. Spine motility: phenomenology, mechanisms, and function. Neuron 2002;35:1019-27.
94. Morgan JE, Huckfeldt R, Wong RO. Imaging techniques in retinal research. Exp Eye Res 2005;80:297-306.
95. Dunaevsky A, Tashiro A, Majewska A, et al. Developmental regulation of spine motility in the mammalian central nervous system. Proc Natl Acad Sci USA 1999;96:13438-43.
96. Fischer M, Kaech S, Knutti D, et al. Rapid actin-based plasticity in dendritic spines. Neuron 1998;20:847-54.
97. Fifková E. Actin in the nervous system. Brain Res 1985;356: 187-215.
98. Wong WT, Faulkner-Jones BE, Sanes JR, et al. Rapid dendritic remodeling in the developing retina: dependence on neurotransmission and reciprocal regulation by Rac and Rho. J Neurosci 2000;20: 5024-36.
99. Trachtenberg JT, Chen BE, Knott GW, et al. Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature 2002;420:788-94.
100. Grutzendler J, Kasthuri N, Gan WB. Long-term dendritic spine stability in the adult cortex. Nature 2002;420:812-6.
101. Calabrese B, Wilson MS, Halpain S. Development and regulation of dendritic spine synapses. Physiology 2006;21:38-47.
102. Fiala JC, Spacek J, Harris KM. Dendritic spine pathology: cause or consequence of neurological disorders? Brain Res Rev 2002;39: 29-54.
103. Halpain S, Spencer K, Graber S. Dynamics and pathology of dendritic spines. Prog Brain Res 2005;147:29-37.
104. Marin-Padilla M. Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome: a Golgi study. J Comp Neurol 1976;167:63-81.
105. Takashima S, Becker LE, Armstrong DL, et al. Abnormal neuronal development in the visual cortex of the human fetus and infant with Down's syndrome: a quantitative and qualitative Golgi study. Brain Res 1981;225:1-21.
106. Takashima S, Iida K, Mito T, et al. Dendritic and histochemical development and ageing in patients with Down's syndrome. J Intellect Disabil Res 1994;38:265-73.
107. Purpura DP. Dendritic spine 'dysgenesis' and mental retardation. Science 1974;186:1126-8.
108. Purpura DP, Bodick N, Suzuki K, et al. Microtubule disarray in cortical dendrites and neurobehavioral failure. I. Golgi and electron microscopic studies. Brain Res 1982;281:287-9.
109. Wisniewski KE, Segan SM, Miezejeski CM, et al. The Fra(X) syndrome: neurological, electrophysiological, and neuropatholog-ical abnormalities. Am J Med Genet 1991;38:476-80.
110. Marin-Padilla M. Structural abnormalities of the cerebral cortex in human chromosomal aberrations: a Golgi study. Brain Res 1972;44: 625-9.
111. Ferrer I, Galofre E. Dendritic spine anomalies in fetal alcohol syndrome. Neuropediatrics 1987;18:161-3.
112. Wong M. Modulation of dendritic spines in epilepsy: cellular mechanisms and functional implications. Epilepsy Behav 2005;7: 569-77.
113. Catala I, Ferrer I, Galofre E, et al. Decreased numbers of dendritic spines on cortical pyramidal neurons in dementia: a quantitative Golgi study on biopsy samples. Hum Neurobiol 1988;6:255-9.
114. Einstein G, Buranosky R, Crain BJ. Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques. J Neurosci 1994;14:5077-88.
115. El Hachimi KH, Foncin JF Loss of dendritic spines in Alzheimer's disease. CR Acad Sci III 1990;311:397-402.
116. Ferrer I, Gullota F. Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus. Acta Neuropathol 1990; 79:680-5.
117. Scheibel AB. The hippocampus: organizational patterns in health and senescence. Mech Ageing Dev 1979;9:89-102.
118. Stephens B, Mueller AJ, Shering AF, et al. Evidence of a breakdown of corticostriatal connections in Parkinson's disease. Neuroscience 2005;132:741-54.
119. Ferrante RJ, Kowall NW, Richardson EP Jr. Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry. J Neurosci 1991;11: 3877-8.
120. Hendry SH, Calkins DJ. Neuronal chemistry and functional organization in the primate visual system. Trends Neurosci 1998; 21:344-9.
121. Weber AJ, Chen H, Hubbard WC, et al. Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. Invest Ophthalmol Vis Sci 2000;41:1370-9.
122. Yücel YH, Zhang Q, Gupta N, et al. Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol 2000;118:378-84.
123. Yücel YH, Zhang Q, Weinreb RN, et al. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog. Retin Eye Res 2003;22:465-81.
124. Gupta N, Ang LC, de Tilly LN, et al. Human glaucoma and neural degeneration in intracranial optic nerve, lateral geniculate nucleus, and visual cortex. Br J Ophthalmol 2006;90:674-8.
125. Gupta N, Ly T, Zhang Q, et al. Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Exp Eye Res 2007;84:176-84.
126. Conforti L, Adalbert R, Coleman MP. Neuronal death: where does the end begin? Trends Neurosci 2007;30:159-66.
127. Schlamp CL, Li Y, Dietz JA, et al. Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci 2006;7:66.
128. Weber AJ, Kaufman PL, Hubbard WC. Morphology of single ganglion cells in the glaucomatous primate retina. Invest Oph-thalmol Vis Sci 1998;39:2304-20.
129. Pernet V, Di Polo A. Synergistic action of brain-derived neuro-trophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo. Brain 2006;129: 1014-26.
130. Libby RT, Li Y, Savinova OV, et al. Susceptibility to neuro-degeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet 2005;1:17-26.